STMN1 and cervical cancer: Studies have found that high concentrations of propofol enhance the cytotoxicity of paclitaxel against cervical cancer cells by down-regulating stathmin 1 expression, but clinical concentrations of propofol may not have this effect (Jin et al., 2023).